KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Revenue: 2010-2025

Historic Revenue for TherapeuticsMD (TXMD) over the last 15 years, with Sep 2025 value amounting to $784,000.

  • TherapeuticsMD's Revenue rose 43.33% to $784,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 75.19%. This contributed to the annual value of $1.8 million for FY2024, which is 35.25% up from last year.
  • Per TherapeuticsMD's latest filing, its Revenue stood at $784,000 for Q3 2025, which was down 17.65% from $952,000 recorded in Q2 2025.
  • In the past 5 years, TherapeuticsMD's Revenue ranged from a high of $68.6 million in Q4 2022 and a low of $53,000 during Q3 2023.
  • Over the past 3 years, TherapeuticsMD's median Revenue value was $437,000 (recorded in 2023), while the average stood at $481,636.
  • In the last 5 years, TherapeuticsMD's Revenue plummeted by 99.27% in 2023 and then surged by 932.08% in 2024.
  • Quarterly analysis of 5 years shows TherapeuticsMD's Revenue stood at $18.7 million in 2021, then spiked by 267.09% to $68.6 million in 2022, then tumbled by 99.27% to $502,000 in 2023, then soared by 32.87% to $667,000 in 2024, then spiked by 43.33% to $784,000 in 2025.
  • Its Revenue was $784,000 in Q3 2025, compared to $952,000 in Q2 2025 and $393,000 in Q1 2025.